Lilly's baricitinib delivered near-complete scalp hair regrowth at one year for adolescents with severe alopecia areata in Phase 3 BRAVE-AA-PEDS trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. TTAN
2. BRZE
3. CHYM
4. USO
5. QCOM
6. IRT
7. QQQ
8. UNFI
9. SPY
10. ASO

Go back to Lilly's baricitinib delivered near-complete scalp hair regrowth at one year for adolescents with severe alopecia areata in Phase 3 BRAVE-AA-PEDS trial
Incyte Genomics, Inc. (NASDAQ: INCY) Delayed: 124.40 --0 (-0%)
Previous Close $124.40    52 Week High $118.49 
Open $124.40    52 Week Low $55.00 
Day High $124.40    P/E N/A 
Day Low $124.40    EPS $-0.56 
Volume 994       

Lilly (Eli) & Co. (NYSE: LLY) Delayed: 1123.91 --0 (-0%)
Previous Close $1123.91    52 Week High $88.16 
Open $1123.91    52 Week Low $67.88 
Day High $1123.91    P/E 260.16 
Day Low $1123.91    EPS $4.32 
Volume 17,760